HCA
WST icon

Hyperion Capital Advisors’s West Pharmaceutical WST Stock Holding History

Hyperion Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$728K Sell
2,029
-101
-5% -$30.9K 0.33% 32
2026
Q1 		$534K Hold
2,130
– – 0.26% 35
2025
Q4 		$586K Hold
2,130
– – 0.29% 33
2025
Q3 		$559K Hold
2,130
– – 0.3% 32
2025
Q2 		$466K Hold
2,130
– – 0.29% 34
2025
Q1 		$477K Hold
2,130
– – 0.26% 37
2024
Q4 		$698K Sell
2,130
-31
-1% -$9.76K 0.36% 29
2024
Q3 		$649K Hold
2,161
– – 0.3% 32
2024
Q2 		$712K Hold
2,161
– – 0.33% 30
2024
Q1 		$855K Hold
2,161
– – 0.4% 29
2023
Q4 		$761K Sell
2,161
-88
-4% -$31.1K 0.41% 28
2023
Q3 		$844K Hold
2,249
– – 0.46% 28
2023
Q2 		$860K Hold
2,249
– – 0.47% 26
2023
Q1 		$779K Hold
2,249
– – 0.37% 29
2022
Q4 		$529K Hold
2,249
– – 0.26% 34
2022
Q3 		$553K Hold
2,249
– – 0.27% 36
2022
Q2 		$680K Hold
2,249
– – 0.32% 33
2022
Q1 		$924K Hold
2,249
– – 0.35% 29
2021
Q4 		$1.05M Sell
2,249
-92
-4% -$39.6K 0.24% 28
2021
Q3 		$994K Hold
2,341
– – 0.26% 27
2021
Q2 		$841K Sell
2,341
-46
-2% -$15.2K 0.24% 26
2021
Q1 		$673K Sell
2,387
-34
-1% -$9.73K 0.22% 31
2020
Q4 		$686K Sell
2,421
-37
-2% -$10.4K 0.27% 27
2020
Q3 		$676K Sell
2,458
-184
-7% -$48.7K 0.33% 21
2020
Q2 		$600K Sell
2,642
-109
-4% -$21.4K 0.35% 22
2020
Q1 		$419K Hold
2,751
– – 0.3% 28
2019
Q4 		$414K Buy
+2,751
New +$401K 0.22% 27

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Hyperion Capital Advisors's WST Position: Q2 2026 in Review

Hyperion Capital Advisors reduced its West Pharmaceutical (WST) stake by 4.7% in Q2 2026, selling an estimated $30.9K and leaving 2,029 shares worth $728K. The position accounts for 0.33% of the portfolio, ranked #32.

Hyperion Capital Advisors first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.05M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Hyperion Capital Advisors held 2,029 shares of West Pharmaceutical worth $728K as of Q2 2026.
  • Hyperion Capital Advisors sold 101 West Pharmaceutical shares in Q2 2026, an estimated $30.9K.
  • West Pharmaceutical made up 0.33% of Hyperion Capital Advisors's portfolio in Q2 2026, its #32 holding.
  • Hyperion Capital Advisors first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Hyperion Capital Advisors's West Pharmaceutical position peaked at $1.05M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hyperion Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.